当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析 - 现金流量表

春立医疗

(688236)

  

流通市值:49.44亿  总市值:65.74亿
流通股本:2.88亿   总股本:3.84亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金141,900,211.931,162,512,413.23787,304,954.6565,945,760.08
  收到的税费返还-2,825,763.952,825,763.952,729,410.74
  收到其他与经营活动有关的现金6,027,991.2752,637,106.3315,765,417.6311,886,857.73
  经营活动现金流入小计147,928,203.21,217,975,283.51805,896,136.18580,562,028.55
  购买商品、接受劳务支付的现金67,926,712.43375,083,907.55298,567,305.53200,241,512.11
  支付给职工以及为职工支付的现金45,064,602.87187,210,571.05149,971,256.13110,009,221.45
  支付的各项税费13,613,723.3447,771,951.1729,932,778.514,727,332.15
  支付其他与经营活动有关的现金32,251,218.99203,068,928.66152,857,751.91114,097,579.74
  经营活动现金流出小计158,856,257.63813,135,358.43631,329,092.07439,075,645.45
  经营活动产生的现金流量净额-10,928,054.43404,839,925.08174,567,044.11141,486,383.1
二、投资活动产生的现金流量:
  收回投资收到的现金-1,689,000,000744,000,000744,000,000
  取得投资收益收到的现金-15,609,166.866,619,109.046,619,109.04
  处置固定资产、无形资产和其他长期资产收回的现金净额-23,00023,00023,000
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-1,704,632,166.86750,642,109.04750,642,109.04
  购建固定资产、无形资产和其他长期资产支付的现金19,994,053.259,127,974.3548,492,401.8330,116,695.86
  投资支付的现金-1,755,000,000880,000,000860,000,000
  取得子公司及其他营业单位支付的现金-2,200,0002,200,0002,200,000
  投资活动现金流出小计19,994,053.21,816,327,974.35930,692,401.83892,316,695.86
  投资活动产生的现金流量净额-19,994,053.2-111,695,807.49-180,050,292.79-141,674,586.82
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金80,249,991.7418,727,390.818,727,390.8-
  支付其他与筹资活动有关的现金1,159,250.2110,787,049.438,656,570.638,618,899.63
  筹资活动现金流出小计81,409,241.9529,514,440.2327,383,961.438,618,899.63
  筹资活动产生的现金流量净额-81,409,241.95-29,514,440.23-27,383,961.43-8,618,899.63
四、汇率变动对现金及现金等价物的影响-320,760.32-174,841.04-248,760.77-275,701.18
五、现金及现金等价物净增加额-112,652,109.9263,454,836.32-33,115,970.88-9,082,804.53
  加:期初现金及现金等价物余额1,402,472,486.981,139,017,650.661,139,017,650.661,139,017,650.66
  期末现金及现金等价物余额1,289,820,377.081,402,472,486.981,105,901,679.781,129,934,846.13
补充资料:
  净利润-272,625,119.37-114,481,155.04
  资产减值准备-37,239,267.09-26,911,765.98
  固定资产和投资性房地产折旧-27,072,361.18-13,300,195.1
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,072,361.18-13,300,195.1
  无形资产摊销-12,503,614.76-6,376,890.11
  处置固定资产、无形资产和其他长期资产的损失--3,848.03--3,848.03
  公允价值变动损失--8,742,663--4,296,252.04
  财务费用-213,991.25-287,993.88
  投资损失--6,315,413.45--3,217,026.86
  递延所得税--2,488,546.87--3,284,665.23
  其中:递延所得税资产减少--4,223,349.73--4,036,046.42
    递延所得税负债增加-1,734,802.86-751,381.19
  存货的减少--22,322,048.59--38,635,181.65
  经营性应收项目的减少-120,414,618.12-87,729,121.24
  经营性应付项目的增加--37,285,223.07--70,916,603.28
  现金的期末余额-1,402,472,486.98-1,129,934,846.13
  减:现金的期初余额-1,139,017,650.66-1,139,017,650.66
  现金及现金等价物的净增加额-263,454,836.32--9,082,804.53
公告日期2026-04-302026-03-312025-10-312025-08-30
审计意见(境内)标准无保留意见
TOP↑